These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 8483560)

  • 21. Acute non-lymphocytic leukemia following FAM combination adjuvant chemotherapy for gastric and lung adenocarcinoma.
    Bouillet T; Lepage E; Gisselbrecht C; Boiron M
    Nouv Rev Fr Hematol (1978); 1990; 32(3):207-9. PubMed ID: 2120675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluorouracil, doxorubicin, and mitomycin combination versus PELF chemotherapy in advanced gastric cancer: a prospective randomized trial of the Italian Oncology Group for Clinical Research.
    Cocconi G; Bella M; Zironi S; Algeri R; Di Costanzo F; De Lisi V; Luppi G; Mazzocchi B; Rodinò C; Soldani M
    J Clin Oncol; 1994 Dec; 12(12):2687-93. PubMed ID: 7989945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-fluorouracil, adriamycin, and mitomycin-C (FAM) combination chemotherapy in the treatment of advanced gastric cancer.
    MacDonald JS; Woolley PV; Smythe T; Ueno W; Hoth D; Schein PS
    Cancer; 1979 Jul; 44(1):42-7. PubMed ID: 455263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Open phase II with 5-fluorouracil, 4-epi-doxorubicin and mitomycin C (FEM) in advanced gastric cancer.
    Roth A; Zupanc D; Luetić J; Kolarić K
    Tumori; 1990 Feb; 76(1):51-3. PubMed ID: 2108516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer.
    MacDonald JS; Schein PS; Woolley PV; Smythe T; Ueno W; Hoth D; Smith F; Boiron M; Gisselbrecht C; Brunet R; Lagarde C
    Ann Intern Med; 1980 Oct; 93(4):533-6. PubMed ID: 7436184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-fluorouracil, adriamycin, and mitomycin in the treatment of adenocarcinoma of unknown primary.
    Goldberg RM; Smith FP; Ueno W; Ahlgren JD; Schein PS
    J Clin Oncol; 1986 Mar; 4(3):395-9. PubMed ID: 3754004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-dose 5-fluorouracil / folinic acid in combination with three-weekly mitomycin C in the treatment of advanced gastric cancer. A phase II study.
    Hofheinz RD; Hartung G; Samel S; Hochhaus A; Pichlmeier U; Post S; Hehlmann R; Queisser W
    Onkologie; 2002 Jun; 25(3):255-60. PubMed ID: 12119460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of anthracyclines in the treatment of gastric cancer.
    Wadler S; Green M; Muggia F
    Cancer Treat Rev; 1985 Jun; 12(2):105-32. PubMed ID: 3902215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemotherapy of gastric cancer: a review.
    Kelsen D
    Isr J Med Sci; 1988; 24(9-10):557-61. PubMed ID: 3060446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined nonsimultaneous radiation therapy and chemotherapy with 5-FU, doxorubicin, and mitomycin for residual localized gastric adenocarcinoma: a Southwest Oncology Group pilot study.
    Haas CD; Mansfield CM; Leichman LP; Considine B; Bukowski RM
    Cancer Treat Rep; 1983 May; 67(5):421-4. PubMed ID: 6687837
    [No Abstract]   [Full Text] [Related]  

  • 31. A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. International Collaborative Cancer Group.
    Coombes RC; Schein PS; Chilvers CE; Wils J; Beretta G; Bliss JM; Rutten A; Amadori D; Cortes-Funes H; Villar-Grimalt A
    J Clin Oncol; 1990 Aug; 8(8):1362-9. PubMed ID: 2199622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Chemotherapy of gastrointestinal cancer in the advanced stage with a combination of 5-fluorouracil, adriamycin, mitomycin C (FAM). A non-controlled study].
    Grieco A; Lasorella A; Astone A; Vagliviello L; Bartoloni C; Barone C
    Clin Ter; 1984 Aug; 110(4):353-8. PubMed ID: 6237871
    [No Abstract]   [Full Text] [Related]  

  • 33. 5-Fluorouracil, doxorubicin (adriamycin) and mitomycin-C (FAM) in advanced gastric cancer: observations on response, patient characteristics, myelosuppression and delivered dosage.
    Biran H; Sulkes A; Biran S
    Oncology; 1989; 46(2):83-7. PubMed ID: 2710481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of sequential addition of the nitrosourea, chlorozotocin, to the FAM combination in advanced gastric cancer.
    Gisselbrecht C; Smith FP; MacDonald JS; Korsmeyer SJ; Boiron M; Woolley PV; Schein PS
    Cancer; 1983 May; 51(10):1792-4. PubMed ID: 6219735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug combinations in the treatment of gastric adenocarcinoma: a randomized Southwest Oncology Group study.
    Panettiere FJ; Haas C; McDonald B; Costanzi JJ; Talley RW; Athens J; Oishi N; Heilbrun LK; Chen TT
    J Clin Oncol; 1984 May; 2(5):420-4. PubMed ID: 6427416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of advanced gastric carcinoma with 5-fluorouracil adriamycin, and mitomycin C (FAM).
    Haim N; Cohen Y; Honigman J; Robinson E
    Cancer Chemother Pharmacol; 1982; 8(3):277-80. PubMed ID: 6897021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemotherapy for advanced pancreatic cancer. A comparison of 5-fluorouracil, adriamycin, and mitomycin (FAM) with 5-fluorouracil, streptozotocin, and mitomycin (FSM).
    Oster MW; Gray R; Panasci L; Perry MC
    Cancer; 1986 Jan; 57(1):29-33. PubMed ID: 2934124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new chemotherapeutic regimen in the treatment of advanced gastric cancer.
    Kozaczka A; Machalski M
    Neoplasma; 1990; 37(1):77-84. PubMed ID: 2320183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5-Fluorouracil, doxorubicin and mitomycin C (FAM) combination chemotherapy for metastatic adenocarcinoma of unknown primary.
    van der Gaast A; Verweij J; Planting AS; Stoter G
    Eur J Cancer Clin Oncol; 1988 Apr; 24(4):765-8. PubMed ID: 3383976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [FAM as a palliative chemotherapy for gastric cancer with bone metastasis].
    Yumoto Y; Okuda T; Shimizu S; Kawase K
    Gan To Kagaku Ryoho; 1996 Jan; 23(1):107-10. PubMed ID: 8546459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.